ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Press
August 6, 2024
12 Sep 2018

Acarix vinner marknadsacceptans i Österrike – nya kunder beställer CADScor®System för att utesluta kranskärlssjukdom

Pressmeddelande Malmö, 12 september 2018 Acarix vinner marknadsacceptans i Österrike - nya kunder beställer CADScor®System för att utes...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
03 Sep 2018

Acarix Clinical Advisory Board meeting held in parallel to ESC-conference in Munich, Germany, confirms validity of its comprehensive clinical study program.

Press releaseMalmö, Sept 3, 2018Acarix Clinical Advisory Board meeting held in parallel to ESC-conference in Munich, Germany, conf...
Continue reading
author-avatar acarix
Press
August 6, 2024
03 Sep 2018

Acarix Clinical Advisory Board meeting held in parallel to ESC-conference in Munich, Germany, confirms validity of its comprehensive clinical study program.

Press release Malmö, Sept 3, 2018 Acarix Clinical Advisory Board meeting held in parallel to ESC-conference in Munich, Germany, confirm...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
03 Sep 2018

Acarix kliniska rådgivare bekräftar validiteten för bolagets omfattande kliniska studieprogram vid ett möte som hölls parallellt med ESC konferensen i München, Tyskland.

PressmeddelandeMalmö den 3 september 2018Acarix kliniska rådgivare bekräftar validiteten för bolagets omfatta...
Continue reading
author-avatar acarix
Press
August 6, 2024
03 Sep 2018

Acarix kliniska rådgivare bekräftar validiteten för bolagets omfattande kliniska studieprogram vid ett möte som hölls parallellt med ESC konferensen i München, Tyskland.

PressmeddelandeMalmö den 3 september 2018 Acarix kliniska rådgivare bekräftar validiteten för bolagets omfattande kliniska studieprogra...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
30 Aug 2018

Swedish hospitals successfully complete Acarix CADScor®System evaluations vs. current best clinical practice for ruling out Coronary Artery Disease.

Press releaseMalmö, August 30, 2018Swedish hospitals successfully complete Acarix CADScor®System evaluations vs. current best ...
Continue reading
author-avatar acarix
Press
August 6, 2024
30 Aug 2018

Swedish hospitals successfully complete Acarix CADScor®System evaluations vs. current best clinical practice for ruling out Coronary Artery Disease.

Press release Malmö, August 30, 2018 Swedish hospitals successfully complete Acarix CADScor®System evaluations vs. current best clinica...
Continue reading
author-avatar acarix
Press
August 6, 2024
30 Aug 2018

Svenska sjukhus slutför framgångsrika utvärderingar av Acarix CADScor®System som jämförts med ledande klinisk praxis för att utesluta kranskärlssjukdom.

Pressmeddelande Malmö, 30 augusti 2018 Svenska sjukhus slutför framgångsrika utvärderingar av Acarix CADScor®System som jämförts med le...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
30 Aug 2018

Svenska sjukhus slutför framgångsrika utvärderingar av Acarix CADScor®System som jämförts med ledande klinisk praxis för att utesluta kranskärlssjukdom.

PressmeddelandeMalmö, 30 augusti 2018Svenska sjukhus slutför framgångsrika utvärderingar av Acarix CADScor®Sys...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
23 Aug 2018

Acarix presenting the CADScor®System at ESC in Munich: A revolutionary technology for early and rapid rule out of Coronary Artery Disease

Press releaseMalmö, Sweden August 23, 2018Acarix presenting the CADScor®System at ESC in Munich:A revolutionary technology for...
Continue reading
author-avatar acarix
Press
August 6, 2024
23 Aug 2018

Acarix presenting the CADScor®System at ESC in Munich: A revolutionary technology for early and rapid rule out of Coronary Artery Disease

Press release Malmö, Sweden August 23, 2018 Acarix presenting the CADScor®System at ESC in Munich:A revolutionary technology for early ...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
23 Aug 2018

Acarix presenterar CADScor®System vid ESC i München: En revolutionerande teknologi för tidig och snabb uteslutning av kranskärlssjukdom

PressmeddelandeMalmö, 23 augusti, 2018Acarix presenterar CADScor®System vid ESC i München: En revolutionerande teknologi ...
Continue reading
  • «
  • ‹
  • 69
  • 70
  • 71
  • 72
  • 73
  • ›
  • »

Acarix AB

Jungmansgatan 12
211 19 Malmö
SE
info@acarix.com

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V6

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.